Home » Topics » Regulatory

Regulatory
RSS

Pulmonary insulin enters phase II

April 26, 1996

EPC-K for pancreatitis

April 26, 1996

Enadoline claimed for treatment of BPH

April 26, 1996

SR-48692 claimed for use as diuretic

April 26, 1996

Update on terfenadine carboxylate progress

April 26, 1996

Scopolamine gel available in U.S. for motion sickness

April 26, 1996

U.S. government claims new antipsychotic compositions

April 26, 1996

Prograf approved for new indication in Japan, launched in France

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Hyal-CT1101 effective in phase III trial

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...